Acrotech Biopharma is classified as operating in the Pharmaceutical Preparation Manufacturing industry, NAICS Code 325412.
Trademark Applications
Trademark applications show the products and services that Acrotech Biopharma is developing and marketing.
Acrotech Biopharma doesn't have any recent trademark applications, indicating Acrotech Biopharma is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
ACROTECH Manufacturing of pharmaceuticals for others
03/29/2021
SPECIALTY THERAPY ACCESS RESOURCES Consultation in the field of the purchase of pharmaceuticals, namely, financial administration of patient reimbursement programs; consultation in the field of the purchase of pharmaceuticals, namely, financial administration of patient reimbursement programs
04/13/2020
KHAPZORY Pharmaceutical preparation for the treatment of folic deficiency, methotrexate rescue, impaired methotrexate elimination, inadvertent overdosage of folic acid antagonists, osteosarcoma, and colorectal indications that is precipitate free when mixed other folate antagonists
10/23/2018
See all trademarks and details in the Full Report.
Market Share of Acrotech Biopharma's Largest Competitors
A competitive analysis shows these companies are in the same general field as Acrotech Biopharma, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Acrotech Biopharma.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Acrotech Biopharma and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.